My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 527

    1.

    Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes" in the Diabetes Control and Complications Trial.

    Kilpatrick ES, Rigby AS, Atkin SL.

    Diabetes Care. 2007 Mar;30(3):707-12.PMID: 17327345 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Estimated glucose disposal rate in assessment of the metabolic syndrome and microvascular complications in patients with type 1 diabetes.

    Chillarón JJ, Goday A, Flores-Le-Roux JA, Benaiges D, Carrera MJ, Puig J, Cano-Pérez JF, Pedro-Botet J.

    J Clin Endocrinol Metab. 2009 Sep;94(9):3530-4. Epub 2009 Jul 7.PMID: 19584183 [PubMed - indexed for MEDLINE]Related articles

    3.

    The prediction of major outcomes of type 1 diabetes: a 12-year prospective evaluation of three separate definitions of the metabolic syndrome and their components and estimated glucose disposal rate: the Pittsburgh Epidemiology of Diabetes Complications Study experience.

    Pambianco G, Costacou T, Orchard TJ.

    Diabetes Care. 2007 May;30(5):1248-54. Epub 2007 Feb 15.PMID: 17303788 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.

    Meigs JB, Rutter MK, Sullivan LM, Fox CS, D'Agostino RB Sr, Wilson PW.

    Diabetes Care. 2007 May;30(5):1219-25. Epub 2007 Jan 26.PMID: 17259468 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control.

    Zhang L, Krzentowski G, Albert A, Lefebvre PJ.

    Diabetes Care. 2001 Jul;24(7):1275-9.PMID: 11423515 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.

    [No authors listed]

    Diabetes. 1995 Aug;44(8):968-83.PMID: 7622004 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group.

    [No authors listed]

    Ann Intern Med. 1998 Apr 1;128(7):517-23.PMID: 9518395 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    [Metabolic syndrome, type 1 diabetes mellitus and insulin resistance]

    Chillarón JJ, Goday A, Pedro-Botet J.

    Med Clin (Barc). 2008 Apr 5;130(12):466-70. Review. Spanish. PMID: 18405504 [PubMed - indexed for MEDLINE]Related articles

    9.

    Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.

    Samaras K, Wand H, Law M, Emery S, Cooper D, Carr A.

    Diabetes Care. 2007 Jan;30(1):113-9. Erratum in: Diabetes Care. 2007 Feb;30(2):455. PMID: 17192343 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.

    [No authors listed]

    Diabetes. 1996 Oct;45(10):1289-98.PMID: 8826962 [PubMed - indexed for MEDLINE]Related articles

    11.

    Leisure time physical activity is associated with poor glycemic control in type 1 diabetic women: the FinnDiane study.

    Wadén J, Tikkanen H, Forsblom C, Fagerudd J, Pettersson-Fernholm K, Lakka T, Riska M, Groop PH; FinnDiane Study Group.

    Diabetes Care. 2005 Apr;28(4):777-82.PMID: 15793172 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from Metascreen, a multicenter diabetes clinic-based survey.

    Metascreen Writing Committee, Bonadonna RC, Cucinotta D, Fedele D, Riccardi G, Tiengo A.

    Diabetes Care. 2006 Dec;29(12):2701-7.PMID: 17130208 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.

    Tong PC, Kong AP, So WY, Yang X, Ho CS, Ma RC, Ozaki R, Chow CC, Lam CW, Chan JC, Cockram CS.

    Diabetes Care. 2007 May;30(5):1206-11. Epub 2007 Jan 26.PMID: 17259472 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial.

    White NH, Sun W, Cleary PA, Danis RP, Davis MD, Hainsworth DP, Hubbard LD, Lachin JM, Nathan DM.

    Arch Ophthalmol. 2008 Dec;126(12):1707-15.PMID: 19064853 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.

    [No authors listed]

    N Engl J Med. 2000 Feb 10;342(6):381-9. Erratum in: N Engl J Med 2000 May 4;342(18):1376. PMID: 10666428 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Improved glycemic control reduces the impact of weight gain on cardiovascular risk factors in type 1 diabetes. The Epidemiology of Diabetes Complications Study.

    Williams KV, Erbey JR, Becker D, Orchard TJ.

    Diabetes Care. 1999 Jul;22(7):1084-91.PMID: 10388972 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study.

    Orchard TJ, Olson JC, Erbey JR, Williams K, Forrest KY, Smithline Kinder L, Ellis D, Becker DJ.

    Diabetes Care. 2003 May;26(5):1374-9.PMID: 12716791 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The metabolic syndrome, insulin resistance, and its surrogates in African and white subjects with type 2 diabetes in South Africa.

    Kalk WJ, Joffe BI.

    Metab Syndr Relat Disord. 2008 Winter;6(4):247-55.PMID: 19067527 [PubMed - indexed for MEDLINE]Related articles

    19.

    Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial.

    [No authors listed]

    Arch Ophthalmol. 1998 Jul;116(7):874-86. Erratum in: Arch Ophthalmol 1998 Nov;116(11):1469. PMID: 9682700 [PubMed - indexed for MEDLINE]Related articles

    20.

    Impact of the metabolic syndrome on macrovascular and microvascular outcomes in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study 78.

    Cull CA, Jensen CC, Retnakaran R, Holman RR.

    Circulation. 2007 Nov 6;116(19):2119-26. Epub 2007 Oct 22.PMID: 17967769 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity